Terri Helman Finkel
Physician at Minden Way, Penn Wynne, PA
License number
Colorado 27545
Issued Date
Jul 10, 1986
Renew Date
May 31, 2001
Expiration Date
May 31, 2001
Type
Physician
Address
Address
415 Minden Way, Penn Wynne, PA 19096
Professional information
Cellular Genes Regulated By Hiv-1 Infection And Methods Of Use Thereof
US Patent:
7405292, Jul 29, 2008
Filed:
Feb 14, 2005
Appl. No.:
11/057484
Inventors:
Terri H. Finkel - Wynnewood PA, US
Jiyi Yin - Swarthmore PA, US
Jiyi Yin - Swarthmore PA, US
Assignee:
The Children's Hospital of Philadelphia - Philadelphia PA
International Classification:
C07H 21/04, A61K 48/00
US Classification:
536 245, 4242071, 424 931, 514 44
Abstract:
This invention provides cellular gene products which have anti-apoptotic activity in HIV-1 infected cells and provides agents for the inhibition of the cellular gene products.
Cellular Genes Regulated By Hiv-1 Infection And Methods Of Use Thereof
US Patent:
7288644, Oct 30, 2007
Filed:
Feb 19, 2003
Appl. No.:
10/368803
Inventors:
Terri H. Finkel - Wynnewood PA, US
Jiyi Yin - Swarthmore PA, US
Jiyi Yin - Swarthmore PA, US
Assignee:
The Children's Hospital of Philadelphia - Philadelphia PA
International Classification:
C07H 21/04, C12N 15/11, A61K 35/00
US Classification:
536 235, 536 231, 435235, 435 6, 435455, 435 2
Abstract:
This invention provides cellular gene products which have anti-apoptotic activity in HIV-1 infected cells. Other pro-apoptotic genes and methods of use thereof are also disclosed. The compositions of the invention may be used to advantage to develop novel therapeutic agents for the treatment of HIV infection. The compositions of the invention may also be used to advantage to develop novel therapeutic agents for the treatment of disorders associated with inordinate cellular apoptosis.
Fluid Planar Lipid Layer-Based Membrane-Anchored Ligand System With Defined Ligand Valency And Methods Of Use Thereof
US Patent:
2004021, Nov 4, 2004
Filed:
Apr 8, 2004
Appl. No.:
10/820262
Inventors:
Terri Finkel - Wynnewood PA, US
Zhengyu Ma - Philadelphia PA, US
Zhengyu Ma - Philadelphia PA, US
International Classification:
G01N033/53, C12N001/00
US Classification:
435/007100, 435/317100
Abstract:
Fluid planar lipid layer-based membrane-anchored ligand systems with defined ligand valency and methods of use thereof are provided.
Methods And Compositions For Increasing Cd4Lymphocyte Immune Responsiveness
US Patent:
2004013, Jul 8, 2004
Filed:
Sep 29, 2003
Appl. No.:
10/673882
Inventors:
Terri Finkel - Wynnewood PA, US
Nithianandan Selliah - Coatesville PA, US
Dennis DeSimone - Roanoke VA, US
Randall Cron - West Grove PA, US
Nithianandan Selliah - Coatesville PA, US
Dennis DeSimone - Roanoke VA, US
Randall Cron - West Grove PA, US
International Classification:
C12N007/00
US Classification:
435/235100
Abstract:
This invention identifies the cellular gene STAT5 as modulating the HIV-1 life cycle in infected cells. Compositions and methods are provided as novel means for the treatment of HIV infection.
Cellular Genes Regulated By Hiv-1 Infection And Methods Of Use Thereof
US Patent:
7994147, Aug 9, 2011
Filed:
Jul 14, 2008
Appl. No.:
12/172731
Inventors:
Terri H. Finkel - Wynnewood PA, US
Jiyi Yin - Perrysburg OH, US
Jiyi Yin - Perrysburg OH, US
Assignee:
The Children's Hospital of Philadelphia - Philadelphia PA
International Classification:
A01N 43/04, A61K 31/70
US Classification:
514 44
Abstract:
This invention provides cellular gene products which have anti-apoptotic activity in HIV-1 infected cells and provides agents for the inhibition of the cellular gene products.
Cellular Genes Regulated By Hiv-1 Infection And Methods Of Use Thereof
US Patent:
8334275, Dec 18, 2012
Filed:
Jun 24, 2011
Appl. No.:
13/168057
Inventors:
Terri H. Finkel - Wynnewood PA, US
Jiyi Yin - Perrysburg OH, US
Jiyi Yin - Perrysburg OH, US
Assignee:
The Children's Hospital of Philadelphia - Philadelphia PA
International Classification:
C12N 15/00
US Classification:
514 44A
Abstract:
This invention provides cellular gene products which have anti-apoptotic activity in HIV-1 infected cells and provides agents for the inhibition of the cellular gene products.
Methods And Compositions For Increasing Cd4Lymphocyte Immune Responsiveness
US Patent:
2005012, Jun 9, 2005
Filed:
Aug 26, 2004
Appl. No.:
10/926749
Inventors:
Terri Finkel - Wynnewood PA, US
International Classification:
A61K031/4745
US Classification:
514291000
Abstract:
Compositions and methods are provided for the treatment of infections by microbes associated with a latent infection.